Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | GAA | P10253 | 1/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | CES1 | P23141 | 2/20 | 0.70 |
| ▸ | CES2 | O00748 | 1/20 | 0.70 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | PAM | P19021 | 2/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.58 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylacetic Acid SCHEMBL27758886 | 1.00 | AKR1B1 (1.00) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL1459 | 1.00 | AKR1B1 (1.00) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL28242469 | 1.00 | AKR1B1 (1.00) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL13618842 | 1.00 | AKR1B1 (1.00) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL1330777 | 1.00 | AKR1B1 (1.00) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL6930087 | 0.97 | AKR1B1 (0.94) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL7214232 | 0.97 | AKR1B1 (0.94) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL6547063 | 0.97 | AKR1B1 (0.94) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL388148 | 0.97 | AKR1B1 (0.94) | AKR1B1ABCC4LMNAGAATSHR | |
| Phenylacetic Acid SCHEMBL11709776 | 0.97 | AKR1B1 (0.94) | AKR1B1ABCC4LMNAGAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109942389-A | The preparation method and application of 1,3- bis- (3,4- halogen phenyl) acetone | 大连大学 | 2019-06-28 | — | — | CN | claimed |
| CN-119212693-A | Combination of taurine glycol and sodium phenylbutyrate for the treatment of amyotrophic lateral sclerosis | 艾米利克斯制药公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-112351974-B | Novel compound 2-amino-2- (1, 2, 3-triazole-4-yl) -1, 3-propanediol derivative capable of directly inhibiting ASM activity and application thereof | 庆北大学校产学协力团 | 2024-01-26 | — | — | CN | disclosed |
| CN-115698321-A | Methods for plasma free RNA analysis | 格里尔公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115282165-A | Natural killer cells from placenta | 细胞结构公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-115137753-A | Natural killer cells from placenta | 细胞结构公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-108473484-B | Compounds useful as TRPM8 modulators | 弗门尼舍公司 | 2021-06-29 | — | — | CN | disclosed |
| EP-3675838-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | Puretecch LYT, Inc. (US) | 2020-07-08 | — | — | EP | disclosed |
| CN-110250007-A | A kind of culture medium broken up again for peanut microspore callus | 林祥艳 | 2019-09-20 | — | — | CN | disclosed |
| WO-2019046491-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | ARIYA THERAPEUTICS, INC. (US) | 2019-03-07 | — | — | WO | disclosed |
| EP-3274434-A1 | PERFUME COMPOSITIONS | Johnson & Johnson Consumer Inc. (US) | 2018-01-31 | — | — | EP | disclosed |
| CN-102483419-B | Utilize the method for apparent metabolic transformation agent, multidimensional intracellular molecules or environment affecting agent diagnosis dysbolism | 博格有限责任公司 | 2017-12-15 | — | — | CN | disclosed |
| CN-103622842-B | Delivery of particles | 宝洁公司 | 2017-10-27 | — | — | CN | disclosed |
| EP-3234094-A1 | IONIC LIQUID SYSTEMS | The Procter and Gamble Company (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2017131818-A1 | PERFUME COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC. (US) | 2017-08-03 | — | — | WO | disclosed |
| CN-102482713-B | Method for diagnosing neoplastic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers | 博格有限责任公司 | 2017-06-30 | — | — | CN | disclosed |
| CN-106344424-A | Sun-proof, moisturizing and anti-aging amino acid cosmetic | 百朗德生物化学(海门)有限公司 | 2017-01-25 | — | — | CN | disclosed |
| WO-2016100123-A1 | IONIC LIQUID SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2016-06-23 | — | — | WO | disclosed |
| CN-1226932-A | Process for inactivation of genes which code for enzymes for catabolism of phenyl acetate, plasmids involved in such process and strains transformed therewith | ANTIBIOTICOS SA (ES) | 1999-08-25 | — | — | CN | disclosed |
| US-5254583-A | Antiinflammatory agents | HEUMANN PHARMA GMBH & CO. (DE) | 1993-10-19 | — | — | US | disclosed |